scholarly journals Potentiality and possibility of Medicinal Plants on Ayurvedic Principle in prevention and treatment of COVID-19

2020 ◽  
Vol 6 (2) ◽  
pp. 100-107 ◽  
Author(s):  
Binay Sen ◽  
◽  
Keyword(s):  
Medicinal Plants ◽  
Vascular System ◽  
Specific Treatment ◽  
Respiratory Illness ◽  
Special Treatment ◽  
Medical Problems ◽  
Epidemic Disease ◽  
Treatment Principle ◽  
Cardio Vascular ◽  
Novel Coronavirus

The novel coronavirus disease 2019 (COVID-19) is a pandemic health emergency, caused by the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2). Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people and those with underlying some medical problems are more likely to develop serious illness. Considering different classical and contemporary viewpoints, the newly identified COVID-19 can be categorized under agantuja vyadhi (exogenous disease) by inception, caused by bhoota (organisms), and transforming to nija (endogenous) leading to disequilibrium of kapha, vata, and pitta doshas and manifestation of clinical features of mainly pranavaha (cardio-pulmonary system), rasavaha (cardio-vascular system) and raktavaha (vascular and RES) srotas dushti (vitiation of channels). In Ayurveda, for a new disease, the treatment principle is designed on the basis of the nature of the disorder, etiology and location. Hence rasayana drugs for epidemic disease, disinfectants for microorganism, dosha (mainly kapha and vata) pacifying drugs and disease-location specific treatment i.e deepana (stomachic), pachana (digestive), shwasahara (anti-dyspnea) and kasahara (anti-cough) are being discussed in this paper. Apart from this, potential of mukhavaishadyakara (mouth cleansing agent), patimarsha-nasya (nasal smearing), krimighna (anti-viral), vishaghna (anti-toxic) and kshara (alkali) dravya (medicinal plants) are being highlighted as these groups of drugs are effective in subsiding kapha, vata, killing microorganism and protecting ojas (immunity) by virtue of their broad spectrum pharmacodynamic properties.

THE EFFECTS OF CORONAVIRUS (COVID-19) IN ENGLISH LANGUAGE AND LITERATURE CLASSROOM OF GUJARAT STATE.

2020 ◽  
pp. 74-79
Author(s):  
Om Joshi
Keyword(s):  
English Language ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Language Teachers ◽  
Special Treatment ◽  
Family Welfare ◽  
Medical Problems ◽  
Gujarat State ◽  
Literature Classroom ◽  
Language And Literature

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness.Coronavirus disease (COVID-19) has taken so many innocent lives, as it spread most of the corner of the world and Gujarat, India oneof them. At present March 2020, most of the institutes and universities do ready to complete the course and repeats the topic in the classroom. As we know that, because of Coronavirus disease (COVID19)University Grants Commission, Health and Family Welfare Department and Education Department, Govt. of Gujaratinstructed to all the institutes and universities to remain closed till further instructions.In this period, researcher wishes to knowthe situation of the English language and literature classroom of Gujarat state. Researcher will refer the online circularsof different institutes and universities of Gujaratstate andwill do the telephonic interviews of English language teachers, based on the data, researcher will discuss the effects of Coronavirus disease (COVID-19) in English language and literature classroom.

Effect of a novel coronavirus in human and its clinical diagnosis and implications by students of community pharmacy

2020 ◽  
Vol 9 (7) ◽  
pp. 1140
Author(s):  
Kanamala Arun Chand Roby ◽  
Singamala Lakshmi Bhargavi ◽  
Gali Devi Sri ◽  
Avula Madhuri ◽  
Sannadi Kamakshi ◽  
...  
Keyword(s):  
Respiratory Infections ◽  
Specific Treatment ◽  
Respiratory Illness ◽  
Respiratory Illnesses ◽  
Runny Nose ◽  
Corona Virus ◽  
Respiratory Tract Illnesses ◽  
Control And Prevention ◽  
Novel Coronavirus ◽  
Corona Viruses

Coronavirus are coming under a broad family of virus that can cause respiratory illnesses such as the common cold, according to the centers for disease control and prevention (CDC). They are usual in many different species of animals, including camels and bats. Unusually, these corona viruses can evolve and infect humans and then spread between humans. Recent examples of this include SARS-CoV and MERS-CoV. 2019 Novel Corona virus (2019-nCoV) is a virus identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. In some cases, the viruses can cause lower-respiratory tract illnesses such as pneumonia and bronchitis. In human corona viruses are currently classified into seven types that are HCoV-229E, HCoV-OC43, HCoV-NL63, SARS-CoV, HKU1, MERS-CoV and 2019-nCoV. These two types of corona virus (MERS-CoV and SARS-CoV) are more dangerous. Some of corona viruses like HCoV-229E, HCo-OC43, HCoNL63 and HKU1 that are continuously circulate in the population of human and cause respiratory infections in human either may children and adults world-wide. They are generally transmitted between animals and humans through sneezing, coughing, touching or shaking hands and making contact with a surface or object. The symptoms of corona virus are sneezing, cough, fatigue, runny nose, sore throat, breathing difficulty and exacerbated. In more severe cases SARS, kidney failure, pneumonia and even death. Diagnosis can be carried out by healthcare provider in laboratory test on respiratory specimens and serum to detect human corona virus. For this virus no specific treatment like vaccines and antiviral drugs but symptoms can be treated.

scholarly journals Why there are and will be less deaths in India due to COVID-19: an insight

2020 ◽  
Vol 7 (8) ◽  
pp. 3301
Author(s):  
Chincholikar Sanjeev Vasantrao
Keyword(s):  
Cardiovascular Disease ◽  
Respiratory Disease ◽  
Kidney Diseases ◽  
Heart Diseases ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
World Health ◽  
Special Treatment ◽  
Medical Problems ◽  
Health Organization

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. It has been declared a pandemic by the World Health Organization which exhibited human-to-human transmissibility and spread rapidly across countries. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Climate, with temperature, humidity, Bacillus Calmette–Guérin (BCG) vaccination, immune status of persons, elderly people, uncontrolled co morbid conditions like heart diseases, diabetes mellitus, hypertension, kidney diseases seems to play an important role in spread and severity of corona virus infection. As reported from MOHFW website, the COVID-19 deaths are more in above 60 years of age with comorbidities cardiovascular disease, diabetes, chronic respiratory disease, and cancer.

scholarly journals A REVIEW TO SUMMARIZE THE AVAILABLE EVIDENCES ON TURMERIC'S (CURCUMA LONGA) MEDICINAL PROPERTIES TO UNDERSTAND THE SCOPE OF ITS EFFICACY IN THE TREATMENT AND PREVENTION OF COVID19 DISEASES.

2020 ◽  
pp. 7-14
Author(s):  
Vd. Anagha Kothadia ◽  
Geeta D. Parulkar
Keyword(s):  
Curcuma Longa ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
Special Treatment ◽  
Intermediate Hosts ◽  
Medical Problems ◽  
Evidence Based Treatment ◽  
Routes Of Administration ◽  
Treatment And Prevention ◽  
Medicinal Properties

The massive outbreak of coronavirus disease (COVID-19) across the world, has affected more than 200 countries and territories which was originated in bats and transmitted to humans through unknown intermediate hosts in the Wuhan seafood market, China, in December of 2019. Most people infected with the COVID-19 virus experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. However, few broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical trials, resulted in clinical recovery. There is no system of medicine has any evidence-based treatment for COVID-19 yet and vaccine is recommended. WHO is helping to accelerate drug research. In India, Ministry of Ayush has issued guidelines which contain preventive and remedial information and advisories for the management of COVID19 symptoms. This review has assembled evidences of Turmeric/Curcuma longa which is one of the ingredient of the ayurvedic preventive majors issued by Ministry of Ayush and revealed various routes of administration of Turmeric /Curcuma longa asserted in Ayurvedic Texts as a remedy and additional preventive majors for COVID 19 symptoms.

scholarly journals The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention

2020 ◽  
Vol 2020 ◽  
pp. 1-7 ◽  
Author(s):  
Hayat Ouassou ◽  
Loubna Kharchoufa ◽  
Mohamed Bouhrim ◽  
Nour Elhouda Daoudi ◽  
Hamada Imtara ◽  
...  
Keyword(s):  
Specific Treatment ◽  
Respiratory Illness ◽  
World Health ◽  
Epidemic Disease ◽  
Major Health Problem ◽  
Major Health ◽  
Hygienic Measures ◽  
Health Organization ◽  
Pharmaceutical Interventions ◽  
Severe Acute Respiratory Illness

Coronavirus Disease 2019 (COVID-19) has become a major health problem causing severe acute respiratory illness in humans. It has spread rapidly around the globe since its first identification in Wuhan, China, in December 2019. The causative virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the World Health Organization (WHO) named the new epidemic disease Coronavirus Disease (COVID-19). The incidence of COVID-19 continues to increase with more than three million confirmed cases and over 244,000 deaths worldwide. There is currently no specific treatment or vaccine against COVID-19. Therefore, in the absence of pharmaceutical interventions, the implementation of precautions and hygienic measures will be essential to control and to minimize human transmission of the virus. In this review, we highlight the epidemiology, transmission, symptoms, and treatment of this disease, as well as future strategies to manage the spread of this fatal coronavirus.

scholarly journals Analysis on Diagnosis of Family Clustering Infection of SARS-CoV-2

2020 ◽  
Author(s):  
Rong Qiu ◽  
Ming-wei Liu ◽  
Chuan Zhao ◽  
Wei-min Li
Keyword(s):  
Clinical Manifestations ◽  
Patient Treatment ◽  
Special Treatment ◽  
Human Interferon ◽  
Epidemic Disease ◽  
Intravenous Drip ◽  
Study Results ◽  
Child Patient ◽  
Novel Coronavirus

Abstract Background: Novel coronavirus (nCoV, SARS-CoV-2) infection has complicated and diversified symptoms, but no special treatment. In this study, diagnosis and treatment of family clustering nCoV infection were analyzed. Methods: The Sichuan Suining Central Hospital received 11 patients with confirmed nCoV virus infection from 4 families during January 23rd, 2020 to February 20th, 2020. Their clinical symptoms, treatment conditions and changes of disease state were reviewed in the present study. Results: In all 4 families, there were 1-2 members in each family who had contact with epidemic disease. Clinical manifestations were: 3 cases had debilitation only, 1 case had cough only, 1 case had diarrhea, 5 cases had fever and cough, and 1 case had blood-stained sputum. According to image changes, no image change was observed in 1 child patient. Multiple focal ground-glass opacities were detected from 2 patients and multiple patchy shadows were observed from 8 patients, especially in lung periphery. Complications: there were hypertension in 3 cases, diabetes in 2 cases, depression in 1 cases and hypertension and diabetes in 1 case. Moreover, there’s one patient who had rheumatic heart disease and received mitral and aortic valve replacement 2 years ago. All 11 cases divided into mild type (1 child patient), moderate type (8 patients), severe type (1 patient) and critical type (1 patient). Treatment: 11 patients were treated with intravenous drip of ribavirin injection (adult 0.5g/time; child15mg/kg.time,twice per day) and lopinavir/ritonavior (adult: 2 tablets/ time; child: 1/2 tablets/times, twice per day) for 6-12 days, accompanied with appropriate amount of intravenous drip of antibiotics. Discharge: After treatment, 11 patients met the discharge criteria and were allowed to discharge. Adverse reactions: 4 patients had loose stools and abdominal discomfort, and another 2 cases had diarrhea. Conclusions: SARS-CoV-2 infection have complicated and diversified symptoms, which shall be identified according to epidemic history and novel coronavirus nucleic acid test. In particular, the whole family in which there’s a patient with confirmed SARS-CoV-2 shall be isolated for screening in addition to the patient. The lopinavir/ritonavior administration combined with ribavirin or recombinant Human Interferon (RHI) α2b is effective, accompanied with mild adverse reaction.

scholarly journals Medicinal plants for the treatment of snakebites among the rural populations of Indian subcontinent: An indication from the traditional use To pharmacological confirmation

2018 ◽  
Vol 8 (5) ◽  
pp. 62-68
Author(s):  
Malathi Ramaswamy ◽  
Sivakumar Duraikannu ◽  
Chandrasekar Solaimuthu
Keyword(s):  
Medicinal Plants ◽  
Indian Subcontinent ◽  
Specific Treatment ◽  
Snake Venoms ◽  
Medical Problems ◽  
Traditional Use ◽  
Permanent Disability ◽  
Lethal Effects ◽  
Herbal Plants ◽  
Inhibitory Potential

Snakebite is one of the important medical problems that affect the public health due to their high morbimortality. Most of the snake venoms produce intense lethal effects, which could lead to impermanent or permanent disability or in often death to the victims. The accessible specific treatment was using the antivenom serum separated from envenomed animals, whose efficiency is reduced against these lethal actions but it has a serious side effects. In this circumstance, this review aimed to provide an updated overview of herbal plants used popularly as antiophidic agents and discuss the main species with pharmacological studies supporting the uses, with prominence on plants inhibiting the lethal effects of snake envenomation amongst the rural tribal peoples of India. There are several reports of the accepted use of herbal plants against snakebites worldwide. In recent years, many studies have been published to giving pharmacological confirmation of benefits of several vegetal species against local effects induced by a broad range of snake venoms, including inhibitory potential against hyaluronidase, phospholipase, proteolytic, hemorrhagic, myotoxic, and edematogenic activities. In India, a variety of herbal plants are used to cure against the snakebites and other poisonous bites, used either in alone or in combination with other herbal agents. The present study was designed to formulate an attempt to bring together information on medicinal plants that are grown and used for snakebite treatment in India. From a variety of literature sources, data have been compiled with prominence on the plants, family, parts used, etc., depending on the availability of information.

scholarly journals A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management

2021 ◽  
Vol 12 ◽  
Author(s):  
Muhammad Harris Shoaib ◽  
Farrukh Rafiq Ahmed ◽  
Muhammad Sikandar ◽  
Rabia Ismail Yousuf ◽  
Muhammad Talha Saleem
Keyword(s):  
Large Scale ◽  
Specific Treatment ◽  
Respiratory Illness ◽  
The Elderly ◽  
Phase Iii ◽  
Healthy Population ◽  
Wuhan City ◽  
Immunosuppressed Patients ◽  
Novel Coronavirus ◽  
Severe Acute Respiratory Illness

The 2019 novel coronavirus (2019-nCoV), commonly known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), was first revealed in late 2019 in Wuhan city, Hubei province, China. It was subsequently spread globally and thereby declared as a pandemic by WHO in March 2020. The disease causes severe acute respiratory illness and is highly contagious due to the fast-onward transmission. As of the mid of November 2020, the disease has affected 220 countries with more than 16 million active cases and 1.3 million deaths worldwide. Males, pregnant women, the elderly, immunosuppressed patients, and those with underlying medical conditions are more vulnerable to the disease than the general healthy population. Unfortunately, no definite treatment is available. Although remdesivir as an antiviral had been approved for use in those above 12 years of age and 40 kg weight group, it has been observed to be ineffective in large-scale SOLIDARITY trials by WHO. Moreover, dexamethasone has been found to increase the recovery rate of ventilated patients; oxygen and inhaled nitric oxide as a vasodilator have been given emergency expanded access. In addition, more than 57 clinical trials are being conducted for the development of the vaccines on various platforms. Two vaccines were found to be significantly promising in phase III results. It is concluded that till the approval of a specific treatment or development of a vaccine against this deadly disease, the preventive measures should be followed strictly to reduce the spread of the disease.

scholarly journals Coronavirus Pandemic: Emergence, Transmission, Preventive Measures and Management

1970 ◽  
Vol 8 (2) ◽  
pp. 45-49
Author(s):  
Mahaveer Prasad Khinchi ◽  
Mohd. Shahid Khan ◽  
Simranjeet Singh Saluja
Keyword(s):  
Preventive Measures ◽  
Respiratory Illness ◽  
Chronic Respiratory Disease ◽  
World Health ◽  
Medical Problems ◽  
Public Places ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Spread Of Infection ◽  
Meat Market

Coronavirus is found in animals and, rarely, can be transmitted from animals to humans and then spread person to person. An occurrence of the coronavirus infection (COVID-19) in China is causing global concern. It came from a seafood and meat market in Wuhan, China, in December 2019. It has since spread to many countries around the world including India. World Health Organization (WHO) declared novel coronavirus eruption a “pandemic” on March 11th, 2020. Patients infected with the COVID-19 virus will experience mild to moderate respiratory illness. Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Prevent spread of infection by washing hands or using an alcohol based rub frequently and not touching face. This virus transmits primarily through droplets of saliva or discharge from the nose when adiseased person coughs or sneezes, so it’s important to cover face by mask and coughing into a flexed elbow at public places. Currently there are no specific vaccines or treatments for COVID-19. In this review, we summarize recent information about the emergence, tansmission, preventive measures and therapeutic options available now.    

Sign in / Sign up

Export Citation Format

Share Document